Cargando…

Quantitative Benefit–Risk Assessment: State of the Practice Within Industry

BACKGROUND: Benefit–risk assessments for medicinal products and devices have advanced significantly over the past decade. The purpose of this study was to characterize the extent to which the life sciences industry is utilizing quantitative benefit–risk assessment (qBRA) methods. METHODS: Semi-struc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Meredith Y., van Til, Janine, DiSantostefano, Rachael L., Hauber, A. Brett, Marsh, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864811/ https://www.ncbi.nlm.nih.gov/pubmed/33111177 http://dx.doi.org/10.1007/s43441-020-00230-3

Ejemplares similares

Exploring Decisional Conflict With Measures of Numeracy and Optimism in a Stated Preference Survey
por: Sutphin, Jessie, et al.
Publicado: (2021)

Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2013)

Using Societal Values to Inform Public Health Policy During the COVID-19 Pandemic: The Role of Health Preference Research
por: DiSantostefano, Rachael L., et al.
Publicado: (2021)

Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold Technique
por: Veldwijk, Jorien, et al.
Publicado: (2023)

Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania
por: Simons, Gwenda, et al.
Publicado: (2022)

Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis
por: Hinds, David R, et al.
Publicado: (2016)

Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations
por: Simons, Gwenda, et al.
Publicado: (2022)

Parent Preferences for Delaying Insulin Dependence in Children at Risk of Stage III Type 1 Diabetes
por: DiSantostefano, Rachael L., et al.
Publicado: (2020)

Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project
por: Falahee, Marie, et al.
Publicado: (2021)

Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance
por: Simons, Gwenda, et al.
Publicado: (2022)

Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)
por: Quint, Jennifer K, et al.
Publicado: (2014)

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2014)

The frequency of, and adherence to, single maintenance and reliever therapy instructions in asthma: a descriptive analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2016)

Risk of Pneumonia with Inhaled Corticosteroid versus Long-Acting Bronchodilator Regimens in Chronic Obstructive Pulmonary Disease: A New-User Cohort Study
por: DiSantostefano, Rachael L., et al.
Publicado: (2014)

Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison
por: Whichello, Chiara, et al.
Publicado: (2020)

Methodological Priorities for Patient Preferences Research: Stakeholder Input to the PREFER Public–Private Project
por: Smith, Ian P., et al.
Publicado: (2021)

Correction to: Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis
por: El Baou, Céline, et al.
Publicado: (2017)

Multimethod quantitative benefit‐risk assessment of treatments for moderate‐to‐severe osteoarthritis
por: Mauer, Jonathan, et al.
Publicado: (2022)

Social determinants of health associated with COVID-19 severity during pregnancy: a multinational cohort study (in the International Registry of Coronavirus Exposure in Pregnancy)
por: Mack, Jasmine A, et al.
Publicado: (2022)

A Structured Benefit-Risk Assessment Operating Model for Investigational Medicinal Products in the Pharmaceutical Industry
por: Sullivan, Tim, et al.
Publicado: (2023)

Current Standards and Practices Within the Therapy Dog Industry: Results of a Representative Survey of United States Therapy Dog Organizations
por: Serpell, James A., et al.
Publicado: (2020)

Benefits of the horticulture industry
Publicado: (2004)

Patients’ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection
por: Kauf, Teresa L., et al.
Publicado: (2012)

Are Gastroenterologists Less Tolerant of Treatment Risks than Patients? Benefit-Risk Preferences in Crohn's Disease Management
por: Johnson, F. Reed, et al.
Publicado: (2010)

The Wine Industry By-Products: Applications for Food Industry and Health Benefits
por: Ferrer-Gallego, Raúl, et al.
Publicado: (2022)

Physician and patient benefit–risk preferences from two randomized long-acting injectable antipsychotic trials
por: Katz, Eva G, et al.
Publicado: (2016)

Practice nurse chlamydia testing in Australian general practice: a qualitative study of benefits, barriers and facilitators
por: Lorch, Rebecca, et al.
Publicado: (2015)

Engaging Industry in Health Professions’ Education: Benefits and Challenges
por: Kenny, Belinda, et al.
Publicado: (2023)

Investigations into within- and between-subject resting-state amplitude variations
por: Bijsterbosch, Janine, et al.
Publicado: (2017)

The benefits and threats of research partnerships with industry
por: DuVal, Gordon
Publicado: (2005)

Psychological benefits of yoga in industrial workers
por: Bhat, Pookala Shivaram, et al.
Publicado: (2012)

Mechanisms within the Parietal Cortex Correlate with the Benefits of Random Practice in Motor Adaptation
por: Thürer, Benjamin, et al.
Publicado: (2017)

Knowledge of Predatory Practices within the Substance Use Disorder Treatment Industry: Development of a Measurement Instrument
por: Farmer, Antoinette Y., et al.
Publicado: (2022)

Patient and physician preferences for ulcerative colitis treatments in the United States
por: Boeri, Marco, et al.
Publicado: (2019)

Industrialization of Quantitative Systems Pharmacology
por: Topp, Brian, et al.
Publicado: (2019)

Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease
por: Weernink, Marieke G. M., et al.
Publicado: (2016)

Benefits of Increasing Greenness on All-Cause Mortality in the Largest Metropolitan Areas of the United States Within the Past Two Decades
por: Brochu, Paige, et al.
Publicado: (2022)

Association of State Medicaid Expansion With Hospital Community Benefit Spending
por: Kanter, Genevieve P., et al.
Publicado: (2020)

CERN's innovations mean real benefits for industry
Publicado: (2005)

Challenges and Emerging Technologies within the Field of Pediatric Actigraphy
por: Galland, Barbara, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4ths039hl55l7rublqqs0rdjqc